SC 13G/A:大量保有報告書(訂正)-Invus Public Equities, L.P.(6.0%),Invus Public Equities Advisors, LLC(6.0%)など
SILENCE THERAPEUTICS PLC | SC 13D/A:大量保有報告書(訂正)-Richard Ian Griffiths(16.9%),Ora Capital Limited(7.8%)
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-Lombard Odier Asset Management (USA) Corp(10.4%)
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-Deep Track Capital, LP(5.43%),Deep Track Biotechnology Master Fund, Ltd.(5.43%)など
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-THE GOLDMAN SACHS GROUP, INC.(2.2 %),GOLDMAN SACHS & CO. LLC(2.2 %)
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-Invus Public Equities, L.P.(7.8%),Invus Public Equities Advisors, LLC(7.8%)など
SILENCE THERAPEUTICS PLC | SC 13G:大量保有報告書-Invus Public Equities, L.P.(6.8%),Invus Public Equities Advisors, LLC(6.8%)など
SILENCE THERAPEUTICS PLC | SC 13D/A:大量保有報告書(訂正)-Richard Ian Griffiths(26.58%)
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-TCG Crossover GP I, LLC(5.9%),TCG Crossover Fund I, L.P.(5.9%)など
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-Lombard Odier Asset Management (USA) Corp(10.8%)
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正)-THE GOLDMAN SACHS GROUP, INC.(5.1 %),GOLDMAN SACHS & CO. LLC(5.1 %)
SILENCE THERAPEUTICS PLC | SC 13D/A:大量保有報告書(訂正)-Richard Ian Griffiths(25.42%)
SILENCE THERAPEUTICS PLC | SC 13G:大量保有報告書: 大量保有報告書-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%)など
SILENCE THERAPEUTICS PLC | SC 13G:大量保有報告書: 大量保有報告書-TCG Crossover Management, LLC(5.9%)
SILENCE THERAPEUTICS PLC | SC 13D/A:大量保有報告書(訂正): 大量保有報告書(訂正)-Richard Ian Griffiths(28.4%)
SILENCE THERAPEUTICS PLC | SC 13D:大量保有報告書: 大量保有報告書-Richard Ian Griffiths(27.0%)
SILENCE THERAPEUTICS PLC | SC 13G:大量保有報告書: 大量保有報告書-Robert Quested(7.81%)
SILENCE THERAPEUTICS PLC | SC 13G:大量保有報告書: 大量保有報告書-Richard Ian Griffiths(23.05%)
SILENCE THERAPEUTICS PLC | SC 13G/A:大量保有報告書(訂正): 大量保有報告書(訂正)-Lombard Odier Asset Management (USA) Corp(11.6%)
SILENCE THERAPEUTICS PLC | SC 13G:大量保有報告書: 大量保有報告書-Mallinckrodt plc(5.64%),Cache Holdings Limited(5.64%)
データなし